Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $218,938 | 141 | 82.7% |
| Travel and Lodging | $19,725 | 117 | 7.4% |
| Consulting Fee | $16,830 | 8 | 6.4% |
| Food and Beverage | $8,915 | 434 | 3.4% |
| Education | $406.43 | 6 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $250,736 | 422 | $0 (2024) |
| UCB, Inc. | $4,098 | 22 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $3,203 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,421 | 38 | $0 (2024) |
| ABBVIE INC. | $750.90 | 43 | $0 (2024) |
| Galderma Laboratories, L.P. | $655.77 | 27 | $0 (2024) |
| Janssen Biotech, Inc. | $377.80 | 17 | $0 (2024) |
| Allergan Inc. | $298.38 | 5 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $295.73 | 12 | $0 (2023) |
| PFIZER INC. | $293.26 | 28 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,133 | 63 | Lilly USA, LLC ($10,998) |
| 2023 | $54,009 | 103 | Lilly USA, LLC ($48,770) |
| 2022 | $48,677 | 80 | Lilly USA, LLC ($48,331) |
| 2021 | $47,257 | 86 | Lilly USA, LLC ($44,134) |
| 2020 | $30,263 | 59 | Lilly USA, LLC ($30,012) |
| 2019 | $69,425 | 193 | Lilly USA, LLC ($68,315) |
| 2018 | $902.72 | 51 | Galderma Laboratories, L.P. ($153.80) |
| 2017 | $1,145 | 71 | Galderma Laboratories, L.P. ($215.04) |
All Payment Transactions
706 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Immunology | ||||||
| 12/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $37.83 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $651.96 | General |
| 12/12/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $404.35 | General |
| 12/12/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $232.20 | General |
| 12/10/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $29.54 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $54.80 | General |
| 11/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: Immunology | ||||||
| 11/06/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $130.21 | General |
| 11/04/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Dermatology | ||||||
| 10/26/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $83.03 | General |
| 10/26/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $50.84 | General |
| Category: DERMATOLOGY | ||||||
| 10/24/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $48.69 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $124.04 | General |
| 10/17/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $106.61 | General |
| 10/14/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Travel and Lodging | Cash or cash equivalent | $111.22 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Travel and Lodging | Cash or cash equivalent | $96.93 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Travel and Lodging | Cash or cash equivalent | $80.00 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | Cash or cash equivalent | $40.57 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Travel and Lodging | Cash or cash equivalent | $34.76 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | Cash or cash equivalent | $22.24 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | Cash or cash equivalent | $8.04 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 427 | 804 | $72,510 | $27,021 |
| 2022 | 9 | 339 | 600 | $59,560 | $21,497 |
| 2021 | 8 | 275 | 482 | $49,971 | $19,406 |
| 2020 | 10 | 636 | 1,152 | $59,074 | $29,425 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 79 | 97 | $14,824 | $5,716 | 38.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 50 | $10,795 | $4,452 | 41.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 71 | 87 | $9,827 | $3,418 | 34.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 50 | 50 | $9,454 | $3,290 | 34.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 33 | 38 | $7,216 | $2,700 | 37.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 61 | 372 | $4,147 | $1,761 | 42.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $5,075 | $1,588 | 31.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 21 | 30 | $3,252 | $1,310 | 40.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 18 | 20 | $3,393 | $1,147 | 33.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 20 | 20 | $2,440 | $882.88 | 36.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 22 | $2,088 | $757.68 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 61 | 75 | $11,527 | $4,425 | 38.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 46 | 46 | $8,727 | $2,983 | 34.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 36 | $7,821 | $2,965 | 37.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 29 | 37 | $7,046 | $2,681 | 38.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $7,093 | $2,534 | 35.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 62 | 72 | $8,153 | $2,475 | 30.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 27 | 27 | $4,657 | $1,627 | 34.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 46 | 266 | $3,011 | $1,250 | 41.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 16 | $1,525 | $557.70 | 36.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 58 | 58 | $11,000 | $4,190 | 38.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 52 | $8,028 | $3,470 | 43.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 28 | 28 | $7,973 | $2,729 | 34.2% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 25 | 34 | $6,456 | $2,640 | 40.9% |
| 17000 | Destruction of skin growth | Office | 2021 | 46 | 54 | $5,992 | $2,287 | 38.2% |
About Dr. Travis James, DO
Dr. Travis James, DO is a Dermatology healthcare provider based in Providence, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2012. The National Provider Identifier (NPI) number assigned to this provider is 1477818920.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Travis James, DO has received a total of $264,813 in payments from pharmaceutical and medical device companies, with $13,133 received in 2024. These payments were reported across 706 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($218,938).
As a Medicare-enrolled provider, James has provided services to 1,677 Medicare beneficiaries, totaling 3,038 services with total Medicare billing of $97,349. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology, Dermatology
- Location Providence, UT
- Active Since 07/11/2012
- Last Updated 05/15/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1477818920
Products in Payments
- TALTZ (Drug) $177,916
- OLUMIANT (Drug) $33,846
- Olumiant (Drug) $18,875
- COSENTYX (Drug) $1,866
- Humira (Biological) $452.46
- COSENTYX (Biological) $401.34
- Cimzia (Drug) $300.41
- EUCRISA (Drug) $293.26
- SKYRIZI (Biological) $264.02
- DUPIXENT (Biological) $256.49
- Tremfya (Drug) $196.25
- EBGLYSS (Drug) $165.50
- Enbrel (Biological) $152.25
- ADBRY (Biological) $135.96
- TREMFYA (Drug) $119.79
- Sotyktu (Drug) $112.84
- Bimzelx (Biological) $109.39
- VTAMA (Drug) $92.77
- LIBTAYO (Biological) $87.53
- Zoryve (Drug) $80.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Providence
Dr. Martin Weinstock, Md,Phd, MD,PHD
Dermatology — Payments: $141,020
Abrar Qureshi, Md, Mph, MD, MPH
Dermatology — Payments: $81,973
Helena Kuhn, Md, MD
Dermatology — Payments: $31,120
Dr. Scott Hammerman, M.d, M.D
Dermatology — Payments: $16,741
Laura Della Torre, M.d, M.D
Dermatology — Payments: $8,493
Dr. Rachel Hoffmann, M.d, M.D
Dermatology — Payments: $3,306